We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NATH:NASDAQNathan's Famous, Inc. Analysis

Data as of 2026-05-26 - not real-time

$101.07

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Nathan's Famous (NATH) is trading at $101.07, essentially flat against its 20‑day, 50‑day and 200‑day moving averages (~$101), indicating a neutral price stance. The 14‑day RSI sits at 51.5, confirming the lack of momentum extremes. A bearish MACD histogram (‑0.0046) and a decreasing volume trend suggest short‑term pressure despite the stable averages. The stock’s beta of roughly 0.3 and 30‑day volatility under 6% point to low market‑risk exposure. However, the Fear & Greed Index at 91.8 signals heightened market optimism that could inflate price expectations. Fundamentally, revenue grew 9% YoY to $158 M with a solid 15% operating margin, supporting the current earnings multiple of 19.4× PE.
The discounted cash‑flow model values the company at about $82 per share, well below the market price, flagging an overvaluation gap. The dividend yield of 1.98% and a payout ratio of 38% are backed by $19 M of free cash flow, suggesting the dividend is sustainable. A negative book value per share (‑$3.73) drives an anomalous price‑to‑book of ‑27, highlighting balance‑sheet weakness. Net debt of roughly $29 M (debt $53 M less cash $24 M) is modest relative to the $414 M market cap, limiting financial distress risk. The decreasing trading volume (≈11 k today versus 10‑day average of 18.8 k) raises a moderate liquidity concern. Overall, the mix of steady earnings, attractive dividend and low beta is offset by an elevated price relative to intrinsic value, implying a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near key support level
  • Bearish MACD histogram
  • Decreasing trading volume

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Market price exceeds DCF fair value
  • Elevated Fear & Greed index suggesting over‑optimism
  • Negative book value and high price‑to‑book ratio

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Consistent revenue growth and solid operating margins
  • Sustainable dividend backed by free cash flow
  • Low beta and low volatility reducing market risk

Key Metrics & Analysis

Financial Health

Revenue Growth8.90%
Profit Margin13.59%
P/E Ratio19.4
ROA39.87%
P/B Ratio-27.1
Op. Cash Flow$22.5M
Free Cash Flow$19.2M

Technical Analysis

TrendNeutral
RSI51.5
Support$99.77
Resistance$101.74
MA 20$100.92
MA 50$100.91
MA 200$101.20
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

Fair Value$82.11
GradeOvervalued
TypeBlend
Dividend Yield1.98%

Risk Assessment

Beta0.44
Volatility5.98%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.